Phase II trial of capecitabine combined with docetaxel in previously treated patients with non-small cell lung cancer: A randomized controlled study

Author：                        

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.3, Iss.4, 2012-01, pp. : 761-766

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II NCCTG Study of Irinotecan and Docetaxel in Previously Treated Patients with Non-Small Cell Lung Cancer

By Molina Julian   Nikcevich Daniel   Hillman Shauna   Geyer Susan   Drevyanko Timothy   Jett James   Verdirame Joseph   Tazelaar Henry   Rowland Kendrith   Wos Edward   Kutteh Leila   Nair Suresh   Fitch Tom   Flynn Patrick   Stella Philip   Adjei Alex  

Cancer Investigation, Vol. 24, Iss. 4, 2006-07 ,pp. : 382-389

Informa Healthcare

Access to resources Recommend Favorite

Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer

By Yanagihara Kazuhiro   Yoshimura Kenichi   Niimi Miyuki   Yasuda Hiroyasu   Sasaki Takahiko   Nishimura Takafumi   Ishiguro Hiroshi   Matsumoto Shigemi   Kitano Toshiyuki   Kanai Masashi   Misawa Akiko   Tada Harue   Teramukai Satoshi   Mio Tadashi   Fukushima Masanori  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 5, 2010-10 ,pp. : 913-918

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer

By Lam Elaine   Au Jessie   Otterson Gregory   Guillaume Wientjes M.   Chen Ling   Shen Tong   Wei Yong   Li Xiaobai   Bekaii-Saab Tanios   Murgo Anthony   Jensen Rhonda   Grever Michael   Villalona-Calero Miguel  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1019-1029

Springer Publishing Company

Access to resources Recommend Favorite

Second-line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: A phase II trial

By Tas Faruk   Demir Cumhur   Camlica Hakan   Ustuner Zeki   Topuz Erkan  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 233-240

Humana Press, Inc

Access to resources Recommend Favorite

Gefitinib versus docetaxel in previously treated advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials

By Jiang Jingwei   Huang Lizhen   Liang Xiaohua   Zhou Xinli   Huang Ruofan   Chu Zhaohui   Zhan Qiong  

Acta Oncologica, Vol. 50, Iss. 4, 2011-05 ,pp. : 582-588

Informa Healthcare

Access to resources Recommend Favorite